State Street’s Eton Pharmaceutcials ETON Stock Holding History

State Street’s Portfolio ETON Stock Details ETON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$13.1M	Buy	530,215 +28,290	+6%	+$495K	﹤0.01%	2465
2025 Q4	$8.49M	Buy	501,925 +63,480	+14%	+$1.12M	﹤0.01%	2726
2025 Q3	$9.53M	Buy	438,445 +115,251	+36%	+$1.91M	﹤0.01%	2664
2025 Q2	$4.61M	Buy	323,194 +208,958	+183%	+$3.3M	﹤0.01%	2981
2025 Q1	$1.48M	Buy	114,236 +8,900	+8%	+$134K	﹤0.01%	3341
2024 Q4	$1.4M	Buy	105,336 +23,933	+29%	+$243K	﹤0.01%	3414
2024 Q3	$488K	Hold	81,403	–	–	﹤0.01%	3601
2024 Q2	$268K	Hold	81,403	–	–	﹤0.01%	3734
2024 Q1	$305K	Hold	81,403	–	–	﹤0.01%	3771
2023 Q4	$357K	Hold	81,403	–	–	﹤0.01%	3724
2023 Q3	$339K	Buy	81,403 +10,400	+15%	+$40.1K	﹤0.01%	3771
2023 Q2	$248K	Hold	71,003	–	–	﹤0.01%	3933
2023 Q1	$273K	Hold	71,003	–	–	﹤0.01%	3958
2022 Q4	$199K	Hold	71,003	–	–	﹤0.01%	4100
2022 Q3	$149K	Sell	71,003 -6,900	-9%	-$17.2K	﹤0.01%	4263
2022 Q2	$204K	Sell	77,903 -13,700	-15%	-$46K	﹤0.01%	4185
2022 Q1	$399K	Buy	91,603 +7,831	+9%	+$30.8K	﹤0.01%	4135
2021 Q4	$359K	Hold	83,772	–	–	﹤0.01%	4123
2021 Q3	$422K	Hold	83,772	–	–	﹤0.01%	4043
2021 Q2	$516K	Sell	83,772 -182,523	-69%	-$1.35M	﹤0.01%	3839
2021 Q1	$1.95M	Buy	266,295 +21,900	+9%	+$187K	﹤0.01%	3448
2020 Q4	$1.99M	Buy	244,395 +66,519	+37%	+$513K	﹤0.01%	3383
2020 Q3	$1.41M	Buy	177,876 +26,980	+18%	+$184K	﹤0.01%	3337
2020 Q2	$822K	Buy	+150,896	New	+$749K	﹤0.01%	3457

Other funds holding ETON

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

NPT

National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

WIM

Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

OAM

Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return

State Street's ETON Position: Q1 2026 in Review

State Street increased its Eton Pharmaceutcials (ETON) stake by 5.6% in Q1 2026, buying an estimated $495K and bringing the position to 530,215 shares worth $13.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2465.

State Street first reported a position in ETON in Q2 2020 and has held it in 24 quarters since. 116 funds tracked by Wall St. Rank hold ETON as of Q1 2026.

State Street held 530,215 shares of Eton Pharmaceutcials worth $13.1M as of Q1 2026.
State Street bought 28,290 Eton Pharmaceutcials shares in Q1 2026, an estimated $495K.
Eton Pharmaceutcials made up ﹤0.01% of State Street's portfolio in Q1 2026, its #2465 holding.
State Street first reported a position in Eton Pharmaceutcials in Q2 2020 and has held it in 24 quarters since.
116 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.